Sahil Bajaj | Neuroscience | Research Excellence Award

Published on by Research Awards

Research Excellence Award

Sahil Bajaj is a researcher affiliated with UT MD Anderson Cancer Center, United States, whose indexed research profile is associated with the subject area of Neuroscience. His Scopus record reports 61 documents, 1,158 citations, and an h-index of 22. His research profile is presented here in the context of the International Research Awards and the Research Excellence Award.[2]

Sahil Bajaj
Affiliation UT MD Anderson Cancer Center
Country United States
Scopus ID 55697402800
Documents 61
Citations 1,158
h-index 22
Subject Area Neuroscience
Event International Research Awards
ORCID 0000-0003-0629-6036

Abstract

Sahil Bajaj is affiliated with UT MD Anderson Cancer Center in the United States and is identified within the supplied research information as working in Neuroscience. His Scopus profile, identified by, records 61 documents, 1,158 citations, and an h-index of 22. These indicators provide a bibliometric description of his indexed scholarly activity and citation reach. His ORCID identifier provides an additional persistent researcher identity record. The Research Excellence Award article places these documented indicators within the context of the International Research Awards, while maintaining a distinction between bibliographic measurements and independent judgments concerning research quality, significance, or broader academic influence.[1]

Keywords

Research Excellence Award, Sahil Bajaj, Neuroscience, UT MD Anderson Cancer Center, Scopus, bibliometrics, research impact, scholarly publications, citations, h-index, International Research Awards, ORCID.[1]

Introduction

Researcher profiles provide structured information about scholarly publications, affiliations, identifiers, and citation activity. Scopus is a bibliographic database used to index scholarly literature and provide author-level metrics. The supplied record identifies Sahil Bajaj through Scopus Author ID 55697402800 and reports quantitative indicators for his indexed research output.[1]

Research Profile

The supplied profile associates Sahil Bajaj with UT MD Anderson Cancer Center and the subject area of Neuroscience. The reported Scopus record contains 61 documents and 1,158 citations, with an h-index of 22. These figures represent the supplied indexed profile at the time of preparation and may change as databases are updated.[4]

Research Contributions

Within the supplied subject classification, Sahil Bajaj’s research profile is associated with Neuroscience. His indexed publication count indicates sustained scholarly output, while the reported citation total provides a quantitative measure of citations attributed to his indexed documents. Interpretation of individual research contributions requires examination of the underlying publications and their respective contexts.[5]

Publications

The supplied Scopus information reports 61 indexed documents associated with Sahil Bajaj. The document count represents publications or indexed records attributed to the author profile and should be interpreted according to Scopus indexing and author-identification practices. Individual publication titles, journals, and DOI information are not included in the supplied dataset.[2]

Research Impact

The supplied bibliometric indicators include 1,158 citations and an h-index of 22. Citation counts measure references received by indexed scholarly documents, while the h-index combines publication and citation information into a single metric. Such measures can describe aspects of scholarly visibility but do not independently establish research quality or societal impact.[1]

Award Suitability

The supplied profile contains several documented indicators relevant to an academic recognition profile, including institutional affiliation, subject-area classification, publication count, citation count, h-index, Scopus identification, and ORCID registration. These details provide factual background for consideration under the Research Excellence Award within the International Research Awards framework.[2]

Conclusion

Sahil Bajaj’s supplied research profile documents an affiliation with UT MD Anderson Cancer Center and a Neuroscience subject classification. The reported Scopus indicators comprise 61 documents, 1,158 citations, and an h-index of 22. Together with persistent researcher identifiers, these data provide a structured bibliometric overview for academic recognition purposes.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Sahil Bajaj, Author ID 55697402800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55697402800
  2. ORCID. (n.d.). Sahil Bajaj: ORCID record. ORCID.
    https://orcid.org/0000-0003-0629-6036
  3. International Research Awards. (n.d.). International Research Awards.
    https://researchawards.net/
  4. Bajaj, S., Butler, A. J., Drake, D., & Dhamala, M. (2015). Brain effective connectivity during motor-imagery and execution following stroke and rehabilitation. NeuroImage: Clinical, 8, 572–582.
    https://doi.org/10.1016/j.nicl.2015.06.006
  5. Killgore, W. D. S., Vanuk, J. R., Shane, B. R., Weber, M., & Bajaj, S. (2019). A randomized, double-blind, placebo-controlled trial of blue wavelength light exposure on sleep and recovery of brain structure, function, and cognition following mild traumatic brain injury. Neurobiology of Disease, 134, 104679.
    https://doi.org/10.1016/j.nbd.2019.104679

Di Wen | Neuroscience | Best Researcher Award

Published on by Research Awards

Dr. Di Wen | Neuroscience | Best Researcher Award

Dr. Di Wen | The Second Hospital of Hebei Medical University | China

Dr. Di Wen, a dedicated neurologist at the Second Hospital of Hebei Medical University, specializes in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). Her research focuses on gene therapy, autophagy, and mitochondrial protection, with significant findings on the role of OPTN in regulating autophagy and mitophagy. She has contributed to multiple high-impact SCI-indexed publications and leads projects funded by the Hebei Natural Science Foundation. As a member of professional medical committees, Dr. Wen’s work advances therapeutic strategies for ALS, aiming to translate laboratory discoveries into effective clinical interventions that improve patient outcomes.

Author Profile

Scopus

Education

Dr. Di Wen’s journey into the world of neuroscience began with a strong academic foundation rooted in medical sciences, leading to her specialization in neurology. From the early stages of her education, she displayed a keen interest in understanding the complexities of the human nervous system, with a particular focus on neurodegenerative disorders. Her academic path was characterized by rigorous training, in-depth research engagements, and a determination to explore the molecular and cellular underpinnings of diseases like amyotrophic lateral sclerosis (ALS). During her early career, she cultivated expertise in advanced research methodologies, live-cell imaging techniques, and genetic intervention strategies, all of which laid the groundwork for her future breakthroughs in gene therapy and mitochondrial biology.

Experience

As a neurologist at the Department of Neurology, The Second Hospital of Hebei Medical University, Dr. Wen has combined clinical practice with high-level research. Her role bridges patient care and scientific discovery, ensuring that her laboratory findings are guided by real-world medical needs. Beyond her clinical duties, she actively engages in research projects funded by the Hebei Natural Science Foundation (Project Code: H2021206048), where she leads investigations into the genetic and molecular mechanisms underlying ALS. Dr. Wen also collaborates extensively with multidisciplinary teams, including molecular biologists, geneticists, and pharmacologists, to accelerate the translation of benchside discoveries into bedside therapies. Her professional trajectory demonstrates a rare balance of medical excellence and scientific innovation.

Research Focus

Dr. Wen’s research is centered on neurodegenerative diseases, with a primary emphasis on ALS, a condition marked by progressive motor neuron degeneration leading to paralysis. Her landmark studies have shed light on the role of the OPTN gene in regulating autophagy and mitophagy—two crucial cellular processes involved in maintaining neuronal health. Using advanced genetic tools such as LV-sgRNA-OPTN and confocal live-cell imaging, she demonstrated how loss of OPTN impairs mitochondrial function, decreases autophagic flux, and increases oxidative stress in neuronal cells. Her work extends beyond cellular models, exploring gene therapy interventions in SOD1-G93A transgenic mice, where she has shown that enhancing autophagy pathways can protect mitochondria and potentially slow ALS progression. In parallel, Dr. Wen has contributed to research on insulin-like growth factor 1 (IGF-1) as a neuroprotective agent, identifying its role in mitochondrial preservation and apoptosis inhibition. Her prolific publication record in high-impact journals like The FEBS Journal and Brain Research Bulletin underscores the depth and significance of her contributions to the global ALS research community.

Awards and Recognition

Dr. Wen’s dedication to advancing neurological research has been recognized through multiple scientific publications indexed in SCI and other reputable databases. Her papers, some of which have achieved high citation counts, reflect both her innovative approach and her influence in the field of neurobiology. She holds professional memberships in the Sleep and Mood Disorders Professional Committee of Hebei Geriatric Association and the Young Physicians Committee of Hebei Medical Association, affirming her active engagement in professional and academic communities. These affiliations enable her to contribute to collaborative research networks and participate in shaping clinical and research agendas at regional and national levels.

Impact and Influence

The impact of Dr. Wen’s work extends beyond the laboratory, influencing both clinical strategies and future research directions for ALS and related neurodegenerative disorders. By elucidating the molecular mechanisms behind impaired autophagy and mitochondrial dysfunction, she has opened new therapeutic avenues for slowing disease progression. Her studies on gene therapy interventions have the potential to revolutionize treatment protocols, offering hope to patients and their families. Furthermore, her research fosters cross-disciplinary collaboration, encouraging the integration of neurology, genetics, and molecular biology in tackling complex neurological conditions.

Publications

OPTN gene therapy increases autophagy and protects mitochondria in SOD1‐G93A‐expressing transgenic mice and cells.

Author:Wen D; Ji Y; Yuanyuan Li; Duan W; Wang Y; Li Z; Tao M; Li Y
Journal: The FEBS Journal
Year:  2024

The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.

Author: Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
Journal: Brain Research Bulletin
Year: 2019

Systemic administration of scAAV9-IGF1 extends survival in SOD1G93A ALS mice via inhibiting p38 MAPK and the JNK-mediated apoptosis pathway.

Author: Wang W; Wen D; Duan W; Yin J ; Cui C; Wang Y; Liu Y; Li C
Journal: Brain Research Bulletin
Year: 2017

TBK1 is involved in M-CSF-induced macrophage polarization through mediating the IRF5/IRF4 axis.

Author: Li Y, Ji L, Liu C, Li J, Wen D, Li Z , Yu L, Guo M, Zhang S, Duan W , Yi L, Y. Bi Y, Bu H, Li C and Liu Y
Journal:The FEBS Journal
Year: 2024

Intrathecal Delivery of ssAAV9-DAO Extends Survival in SOD1G93A ALS Mice.

Author: Wang W, Duan W, Wang Y, Wen D, Liu Y, Li Z, Hu H, Cui H, Cui C, Lin H, Li C
Journal: Neurochem Research
Year: 2017

Conclusion

Dr. Di Wen, of The Second Hospital of Hebei Medical University, stands as a dedicated clinician–scientist whose work seamlessly bridges advanced research and compassionate patient care. Through her pioneering studies on autophagy, mitophagy, and gene therapy in amyotrophic lateral sclerosis, she has significantly advanced the understanding of disease mechanisms and potential therapeutic strategies. Her contributions, reflected in high-impact publications, professional leadership roles, and collaborative projects, underscore her influence in the neurological research community. With a clear vision for future innovations in personalized neurotherapies, Dr. Wen continues to inspire progress toward effective treatments for complex neurodegenerative diseases.